{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:00:58Z","timestamp":1778839258316,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ajo.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T00:00:54Z","timestamp":1484611254000},"page":"102-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months\u00a06\u201312"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9802-4806","authenticated-orcid":false,"given":"Michael","family":"Wall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Kupersmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Thurtell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather E.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Ann","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Auinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2017.01.004_bib1","first-page":"55","article-title":"Whence pseudotumor cerebri?","volume":"5","author":"Smith","year":"1985","journal-title":"J Clin Neuroophthalmol"},{"issue":"16","key":"10.1016\/j.ajo.2017.01.004_bib2","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the Idiopathic Intracranial Hypertension Treatment Trial","volume":"311","author":"Wall","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2017.01.004_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNO.0000000000000114","article-title":"The Idiopathic Intracranial Hypertension Treatment Trial: design considerations and methods","volume":"34","author":"Friedman","year":"2014","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2017.01.004_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.45.1.13","article-title":"Swelling of the optic nerve head: a staging scheme","volume":"45","author":"Fris\u00e9n","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ajo.2017.01.004_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archophthalmol.2010.94","article-title":"Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale","volume":"128","author":"Scott","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2017.01.004_bib6","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","article-title":"Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2017.01.004_bib7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ajo.2006.06.060","article-title":"Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25","volume":"142","author":"Raphael","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2017.01.004_bib8","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1167\/iovs.08-3225","article-title":"Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials","volume":"50","author":"Suner","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2017.01.004_bib9","series-title":"SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1","author":"Ware","year":"2001"},{"issue":"8","key":"10.1016\/j.ajo.2017.01.004_bib10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1026119331193","article-title":"A six-item short-form survey for measuring headache impact: the HIT-6","volume":"12","author":"Kosinski","year":"2003","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.ajo.2017.01.004_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/WNO.0000000000000327","article-title":"Factors affecting visual field outcomes in the Idiopathic Intracranial Hypertension Treatment Trial","volume":"36","author":"Cello","year":"2016","journal-title":"J Neuroophthalmol"},{"issue":"24","key":"10.1016\/j.ajo.2017.01.004_bib12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1212\/WNL.0000000000001687","article-title":"Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results","volume":"84","author":"Digre","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ajo.2017.01.004_bib13","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00415-015-7838-9","article-title":"CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial","volume":"262","author":"Kattah","year":"2015","journal-title":"J Neurol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939417300107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939417300107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:33:57Z","timestamp":1757597637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939417300107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":13,"alternative-id":["S0002939417300107"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2017.01.004","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months\u00a06\u201312","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}